Literature DB >> 6189783

Therapy for advanced Hodgkin's disease.

V P Choudhry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6189783     DOI： 10.1007/bf02976976

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  10 in total

1.  EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

Authors:  H E SKIPPER; F M SCHABEL; W S WILCOX
Journal:  Cancer Chemother Rep       Date:  1964-02

2.  Quantitative evaluation of chemotherapeutic agents against advanced leukemia in mice.

Authors:  A GOLDIN; J M VENDITTI; S R HUMPHREYS; N MANTEL
Journal:  J Natl Cancer Inst       Date:  1958-09       Impact factor: 13.506

3.  Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.

Authors:  W R Bruce; B E Meeker; W E Powers; F A Valeriote
Journal:  J Natl Cancer Inst       Date:  1969-06       Impact factor: 13.506

4.  Alternating drug combinations in the treatment of advanced Hodgkin's disease.

Authors:  A Santoro; G Bonadonna; V Bonfante; P Valagussa
Journal:  N Engl J Med       Date:  1982-04-01       Impact factor: 91.245

5.  Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.

Authors:  A Santoro; V Bonfante; G Bonadonna
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

6.  The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture.

Authors:  V T DeVita
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

Review 7.  Chemotherapy of advanced Hodgkin's disease.

Authors:  C A Coltman
Journal:  Semin Oncol       Date:  1980-06       Impact factor: 4.929

8.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.

Authors:  G Bonadonna; R Zucali; S Monfardini; M De Lena; C Uslenghi
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

9.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

10.  Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.

Authors:  V T DeVita; R M Simon; S M Hubbard; R C Young; C W Berard; J H Moxley; E Frei; P P Carbone; G P Canellos
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.